Company Performance: Revenue, earnings, and future growth prospects directly impact investor confidence and stock price.

Market Sentiment: Overall investor optimism or pessimism can drive buying or selling pressure, affecting 1CG.AU irrespective of its individual performance.

Industry Trends: Performance of the broader healthcare sector and specifically genomics companies influences investor perception of 1CG.AU.

Economic Conditions: Interest rates, inflation, and economic growth can affect investment decisions and the valuation of 1CG.AU.

News & Announcements: Significant news releases about 1CG.AU, such as drug approvals, partnerships, or clinical trial results, can cause price fluctuations.

Competitor Activity: Actions and performance of competing genomics companies can impact 1CG.AU's market share and investor sentiment.

Regulatory Changes: Changes in healthcare regulations or government policies related to genomics testing can affect 1CG.AU's business environment.

Exchange Rates: Fluctuations in the Australian dollar (AUD) relative to other currencies can impact the value of 1CG.AU for international investors.

Investor Perception: How investors generally feel towards the company.